We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
WHO Prequalification: GMP deviations and suspension.
- Abstract
The article reports on the notice issued by the World Health Organization's (WHO) Medicines Prequalification Programmes to Sandoz South Africa Ltd. on the qualification of a certain drug. It was given due to the result of inspections at their manufacturing facility on problems documented with manufacturing processes of significant deviations from good manufacturing practices (GMP). Furthermore, the health authority strongly advises consumers with options in taking the manufacturer's medications.
- Subjects
WORLD Health Organization; DRUG standards; SANDOZ South Africa Ltd.; CURRENT good manufacturing practices; PHARMACEUTICAL policy; PHARMACEUTICAL industry
- Publication
WHO Drug Information, 2008, Vol 22, Issue 3, p203
- ISSN
1010-9609
- Publication type
Article